DAVID DANTZKER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID DANTZKER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID DANTZKER. DAVID DANTZKER is Director in SURMODICS INC ($SRDX) and Director in Valera Pharmaceuticals Inc ($VLRX).
Latest Insider Trading Transactions of DAVID DANTZKER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 2021 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 56.07 | 334 | 18,727 | 30,139 | 29.8 K to 30.1 K (+1.12 %) |
| Jan 04 2021 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 43.52 | 430 | 18,714 | 28,738 | 28.3 K to 28.7 K (+1.52 %) |
| Nov 13 2020 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Option Exercise | M | 22.58 | 3,575 | 80,724 | 0 | |
| Nov 13 2020 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Payment of Exercise | F | 38.54 | 2,095 | 80,741 | 28,376 | 30.5 K to 28.4 K (-6.88 %) |
| Nov 13 2020 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Buy | M | 22.58 | 3,575 | 80,724 | 30,471 | 26.9 K to 30.5 K (+13.29 %) |
| Jul 02 2020 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 43.24 | 375 | 16,215 | 26,479 | 26.1 K to 26.5 K (+1.44 %) |
| Apr 02 2020 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 33.32 | 487 | 16,227 | 26,104 | 25.6 K to 26.1 K (+1.90 %) |
| Feb 18 2020 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Option Exercise | A | 39.58 | 4,218 | 166,948 | 4,218 | |
| Feb 18 2020 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 0.00 | 1,452 | 0 | 25,617 | 24.2 K to 25.6 K (+6.01 %) |
| Nov 27 2019 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Option Exercise | M | 20.37 | 3,537 | 72,049 | 0 | |
| Nov 27 2019 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Payment of Exercise | F | 42.00 | 1,716 | 72,072 | 23,773 | 25.5 K to 23.8 K (-6.73 %) |
| Nov 27 2019 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Buy | M | 20.37 | 3,537 | 72,049 | 25,489 | 22 K to 25.5 K (+16.11 %) |
| Oct 02 2019 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 45.74 | 306 | 13,996 | 21,952 | 21.6 K to 22 K (+1.41 %) |
| Apr 02 2019 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 43.48 | 321 | 13,957 | 21,322 | 21 K to 21.3 K (+1.53 %) |
| Feb 15 2019 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Option Exercise | A | 55.24 | 2,605 | 143,900 | 2,605 | |
| Feb 15 2019 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 0.00 | 859 | 0 | 21,001 | 20.1 K to 21 K (+4.26 %) |
| Oct 02 2018 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 74.65 | 187 | 13,960 | 19,846 | 19.7 K to 19.8 K (+0.95 %) |
| Jul 03 2018 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 55.20 | 253 | 13,966 | 19,659 | 19.4 K to 19.7 K (+1.30 %) |
| Apr 03 2018 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 38.05 | 367 | 13,964 | 19,406 | 19 K to 19.4 K (+1.93 %) |
| Feb 22 2018 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Option Exercise | A | 27.30 | 5,275 | 144,008 | 5,275 | |
| Feb 22 2018 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 0.00 | 1,739 | 0 | 19,039 | 17.3 K to 19 K (+10.05 %) |
| Jul 05 2017 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 28.15 | 452 | 12,724 | 16,389 | 15.9 K to 16.4 K (+2.84 %) |
| Apr 04 2017 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 24.05 | 530 | 12,747 | 15,937 | 15.4 K to 15.9 K (+3.44 %) |
| Feb 16 2017 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Option Exercise | A | 23.95 | 3,932 | 94,171 | 3,932 | |
| Feb 16 2017 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Option Exercise | A | 23.95 | 3,932 | 94,171 | 3,932 | |
| Feb 16 2017 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 0.00 | 1,252 | 0 | 15,407 | 14.2 K to 15.4 K (+8.84 %) |
| Feb 16 2017 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 0.00 | 1,252 | 0 | 15,407 | 14.2 K to 15.4 K (+8.84 %) |
| Jan 04 2017 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 25.40 | 501 | 12,725 | 14,155 | 13.7 K to 14.2 K (+3.67 %) |
| Oct 04 2016 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 30.09 | 423 | 12,728 | 13,654 | 13.2 K to 13.7 K (+3.20 %) |
| Jul 05 2016 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 23.48 | 543 | 12,750 | 13,231 | 12.7 K to 13.2 K (+4.28 %) |
| Apr 04 2016 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 18.41 | 642 | 11,819 | 12,688 | 12 K to 12.7 K (+5.33 %) |
| Jan 05 2016 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 20.27 | 542 | 10,986 | 12,046 | 11.5 K to 12 K (+4.71 %) |
| Dec 22 2015 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Option Exercise | A | 20.18 | 4,366 | 88,106 | 4,366 | |
| Dec 22 2015 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 0.00 | 1,486 | 0 | 11,504 | 10 K to 11.5 K (+14.83 %) |
| Oct 02 2015 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 21.84 | 492 | 10,745 | 10,018 | 9.5 K to 10 K (+5.16 %) |
| Jul 02 2015 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 23.42 | 459 | 10,750 | 9,526 | 9.1 K to 9.5 K (+5.06 %) |
| May 13 2015 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Sell | S | 24.75 | 11,662 | 288,662 | 9,067 | 20.7 K to 9.1 K (-56.26 %) |
| Apr 02 2015 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Grant | A | 26.02 | 413 | 10,746 | 20,730 | 20.3 K to 20.7 K (+2.03 %) |
| Mar 05 2015 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Option Exercise | M | 12.40 | 10,496 | 130,150 | 0 | |
| Mar 05 2015 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Option Exercise | M | 11.72 | 12,528 | 146,828 | 0 | |
| Mar 05 2015 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Payment of Exercise | F | 24.38 | 11,362 | 277,006 | 20,317 | 31.7 K to 20.3 K (-35.87 %) |
| Mar 05 2015 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Buy | M | 12.40 | 10,496 | 130,150 | 31,679 | 21.2 K to 31.7 K (+49.55 %) |
| Mar 05 2015 | SRDX | SURMODICS INC | DANTZKER DAVID | Director | Buy | M | 11.72 | 12,528 | 146,828 | 21,183 | 8.7 K to 21.2 K (+144.75 %) |
| Apr 19 2007 | VLRX | Valera Pharmaceuti ... | DANTZKER DAVID | Director | Option Exercise | D | 8.85 | 7,500 | 66,375 | 0 | |
| Apr 19 2007 | VLRX | Valera Pharmaceuti ... | DANTZKER DAVID | Director | Option Exercise | D | 3.00 | 15,000 | 45,000 | 0 | |
| Apr 19 2007 | VLRX | Valera Pharmaceuti ... | DANTZKER DAVID | Director | Sell | D | 0.00 | 5,861 | 0 | 0 | 5.9 K to 0 (-100.00 %) |
| Aug 21 2006 | VLRX | Valera Pharmaceuti ... | DANTZKER DAVID | Director | Sell | J | 0.00 | 586,088 | 0 | 0 | 586.1 K to 0 (-100.00 %) |
| Aug 21 2006 | VLRX | Valera Pharmaceuti ... | DANTZKER DAVID | Director | Buy | J | 0.00 | 5,861 | 0 | 586,088 | 580.2 K to 586.1 K (+1.01 %) |
| May 25 2006 | VLRX | Valera Pharmaceuti ... | DANTZKER DAVID | Director | Option Exercise | A | 8.85 | 7,500 | 66,375 | 7,500 | |
| Feb 09 2006 | VLRX | Valera Pharmaceuti ... | DANTZKER DAVID | Director | Option Exercise | C | 6.00 | 428,571 | 2,571,426 | 0 | |
| Feb 09 2006 | VLRX | Valera Pharmaceuti ... | DANTZKER DAVID | Director | Option Exercise | C | 4.35 | 689,655 | 2,999,999 | 0 | |
| Feb 09 2006 | VLRX | Valera Pharmaceuti ... | DANTZKER DAVID | Director | Option Exercise | C | 3.00 | 1,000,000 | 3,000,000 | 0 | |
| Feb 09 2006 | VLRX | Valera Pharmaceuti ... | DANTZKER DAVID | Director | Buy | C | 6.00 | 78,003 | 468,018 | 591,949 | 513.9 K to 591.9 K (+15.18 %) |
| Feb 09 2006 | VLRX | Valera Pharmaceuti ... | DANTZKER DAVID | Director | Buy | C | 4.35 | 149,928 | 652,187 | 513,946 | 364 K to 513.9 K (+41.19 %) |
| Feb 09 2006 | VLRX | Valera Pharmaceuti ... | DANTZKER DAVID | Director | Buy | C | 3.00 | 364,018 | 1,092,054 | 364,018 | 0 to 364 K |
Page: 1